Direct gene transfer into mouse diaphragm
Open Access
- 25 October 1993
- journal article
- Published by Wiley in FEBS Letters
- Vol. 333 (1-2), 146-150
- https://doi.org/10.1016/0014-5793(93)80393-9
Abstract
Direct gene transfer into skeletal muscle is a potential therapeutic strategy for inherited primary myopathies such as Duchenne muscular dystrophy (DMD). In order to affect the life‐expectancy of these patients, it will be necessary to carry out gene therapy on the diaphragm. To this end, we report efficient introduction of pure recombinant plasmid DNA into the mouse diaphragm, without causing significant damage. Application of this approach to the diaphragm of the mdx mouse will provide information on the potential usefulness of gene therapy for the treatment of DMD patients.Keywords
This publication has 23 references indexed in Scilit:
- Restoration of dystrophin‐associated proteins in skeletal muscle of mdx mice transgenic for dystrophin geneFEBS Letters, 1993
- The structural and functional diversity of dystrophinNature Genetics, 1993
- Direct Gene Transfer into Skeletal MuscleIn Vivo: Factors Affecting Efficiency of Transfer and Stability of ExpressionHuman Gene Therapy, 1993
- Widespread long-term gene transfer to mouse skeletal muscles and heart.JCI Insight, 1992
- Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscleFEBS Letters, 1992
- Human dystrophin expression corrects the myopathic phenotype in transgenic mdx miceHuman Molecular Genetics, 1992
- Membrane organization of the dystrophin-glycoprotein complexCell, 1991
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Association of dystrophin and an integral membrane glycoproteinNature, 1989
- Embryonic and neonatal myosin heavy chain in denervated and paralyzed rat skeletal muscleDevelopmental Biology, 1988